We at Precision Antibody™ want to learn about your goals so that we can custom design a project that will cover all your requirements.  We have expertise in a wide range of antibody development from straight-forward projects like an antibody against a peptide, to more “challenging” projects developing an antibody that recognizes a single amino acid mutation, or a specific cleavage site. For a full description of types of antibodies we develop, please check out all of our services.

Precision Antibody™ will design your project through in-depth communication with you. We will discuss multiple approaches to meet your goals.  At the end of the discussion, we will put together a Statement of Work.  Based on the SOW, PA will issue a quote. All the discussions whether we have executed CDA or not will be kept confidential. Once all steps have been approved and finalized, it is time to get started! We understand how important your project is, so we will keep you informed every step along the progression of your project. Our project manager will send you updates after every step and guide you through the next steps. We will work together closely to help you achieve your goal.

Every successful project starts from well-thought out optimized antigen design. Our team of experienced and knowledgeable immunologists will optimize your target for immunization. Our services include but not limited to goal-specific antigen design using our proprietary TED technology that transforms non- or weak immunogens to become highly immunogenic, designing appropriate immunogen targeting multi-span transmembrane proteins, and design strategies for small molecule targets.

Precision Antibody™’s proprietary immunization technology is designed to be tailored to your project. All variables are considered to assure we can obtain the best titer in a short amount of time (1:100,000 in 2 ½ weeks) which guarantees the best antibody. PA also offers specialized immunization strategies for cell based immunizations and other challenging targets.

At the end of the initial immunization cycle, serum titer check will be performed. PA will not fuse unless a sufficient titer (higher than 3-times the control OD at serum dilution of 1:100,000) is obtained. PA uses electrofusion to ensure a high fusion rate and viability. Utilization of well-designed screening method is of a critical importance in the selection of hybridoma clones producing mAb of interest. Precision Antibody™ utilizes screening method most compatible with the intended application of your antibodies to ensure that the selected clones generate antibodies that meet your acceptance criteria.